Last Updated: 17/11/2024
Unravelling Plasmodium vivax transmission to Anopheles mosquitoes: Role of naturally acquired transmission blocking immunity and efficacy of novel vaccine and drug candidates
Objectives
This project is aimed at better understanding transmission of P. vivax, the world’s most widely spread malaria parasite.
Principal Institution
Principal Investigators / Focal Persons
Rationale and Abstract
Using a newly established experimental platform that enables to feed P. vivax infected blood to Anopheles farauti mosquitoes, the team can start researching factors in human blood that determine P. vivax infection success, test new vaccine and drug candidates for their ability to block transmission and thus significantly advance science surrounding this neglected parasite.
External reference
Date
Jan 2018 — Dec 2022
Total Project Funding
$308,036
Funding Details
National Health and Medical Research Council (NHMRC) Australia, Australia
Grant ID: 1141441
AUD 431,000
Country / Project Site(s)
Related Resources
